Shufen Wang
- Developmental Neuroscience top 5%
- Molecular Biology top 10%
- Pluripotent Stem Cells Research 4
- CRISPR and Genetic Engineering 4
- Circular RNAs in diseases 3
- Glutathione Transferases and Polymorphisms 2
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 3
-
- Tissue Engineering and Regenerative Medicine 2
-
- Plant Disease Resistance and Genetics 2
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Shufen Wang
25 papers receiving 827 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Developmental Neuroscience 115
- Molecular Biology 696
- Cancer Research 137
- Aging 15
- Cellular and Molecular Neuroscience 115
Countries citing papers authored by Shufen Wang
This map shows the geographic impact of Shufen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufen Wang more than expected).
Fields of papers citing papers by Shufen Wang
This network shows the impact of papers produced by Shufen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufen Wang. The network helps show where Shufen Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shufen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 21 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 26 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 20 | |
| 14 | 2019 | 32 | |
| 15 | 2019 | 33 | |
| 16 | 2016 | 12 | |
| 17 | 2016 | 1 | |
| 18 | Direct reprogramming of mouse fibroblasts to neural progenitorsbreakdown → | 2011 | 455 |
| 19 | 2008 | 40 | |
| 20 | 2003 | 47 |
About Shufen Wang
Shufen Wang is a scholar working on Cancer Research, Molecular Biology and Hematology, having authored 26 papers that have together received 844 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Pluripotent Stem Cells Research (4 papers), CRISPR and Genetic Engineering (4 papers), Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers), Glutathione Transferases and Polymorphisms (2 papers), Tissue Engineering and Regenerative Medicine (2 papers) and Plant Disease Resistance and Genetics (2 papers). The work is most often cited by research in Developmental Neuroscience (115 citations), Molecular Biology (696 citations) and Cancer Research (137 citations). Shufen Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Maria Talantova, Janghwan Kim, Sheng Ding, Jem Efe, Kang Zhang, Saiyong Zhu, Yuan Xu, Stuart A. Lipton, Feng Jiang and Xia Zhao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.